The aim of this study was to confirm the pathogenic variants, explore the genotype–phenotype correlation and characteristics of Chinese patients with Treacher Collins syndrome (TCS).
Design
Clinical details of 3 TCS family cases and 2 sporadic cases were collected and analyzed. Whole-exome sequencing and Sanger sequencing were conducted to detect causative variants.
Setting
Tertiary clinical care.
Patients
This study included 8 patients clinically diagnosed with TCS who were from 3 familial cases and 2 sporadic cases.
Main Outcome Measures
When filtering the database, variants were saved as rare variants if their frequency were less than 0.005 in the 1000 Genomes Project Database, the Exome Aggregation Consortium (ExAC) browser, and the Novogene database, or they would be removed as common ones. The pathogenic variants identified were verified by polymerase chain reaction. The sequencing results were analyzed by Chromas 2.1 software.
Results
Two novel pathogenic variants (NM_000356.3: c.537del and NM_000356.3: c.1965_1966dupGG) and 2 known pathogenic variants (NM_000356.3: c.1535del, NM_000356.3: c.4131_4135del) were identified within TCOF1 which are predicted to lead to premature termination codons resulting in a truncated protein. There was a known missense SNP (NM_015972.3: c.139G>A) within POLR1D. No phenotype–genotype correlation was observed. Instead, these 8 patients demonstrated the high genotypic and phenotypic heterogeneity of TCS.
Conclusions
This study expands on the pathogenic gene pool of Chinese patients with TCS. Besides the great variation among patients which is similar to international reports, Chinese patients have their own characteristics in clinical phenotype and pathogenesis mutations.
BogerdHPFridellRABensonREHuaJCullenBR. Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay. Mol Cell Biol. 1996;16(8):4207-4214.
2.
BowmanMOldridgeMArcherCO’RourkeAMcParlandJBrekelmansRSellerALesterT. Gross deletions in TCOF1 are a cause of Treacher-Collins-Franceschetti syndrome. Eur J Hum Genet. 2012;20(7):769-777.
3.
ChenYGuoLLiCLShanJXuHSLiJYSunSHaoSJJinLChaiG, et al. Mutation screening of Chinese Treacher Collins syndrome patients identified novel TCOF1 mutations. Mol Genet Genomics. 2018;293(2):569-577.
4.
ChongDKMurrayDJBrittoJATompsonBForrestCRPhillipsJH. A cephalometric analysis of maxillary and mandibular parameters in Treacher Collins syndrome. Plast Reconstr Surg. 2008;121(3):77e-84e.
5.
DauwerseJGDixonJSelandSRuivenkampCAvan HaeringenAHoefslootLHPetersDJBoersACDaumer-HaasCMaiwaldR, et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet. 2011;43(1):20-22.
6.
DixonJDixonMJ. Genetic background has a major effect on the penetrance and severity of craniofacial defects in mice heterozygous for the gene encoding the nucleolar protein treacle. Dev Dyn. 2004;229(4):907-914.
7.
DixonJEdwardsSJAndersonIBrassAScamblerPJDixonMJ. Identification of the complete coding sequence and genomic organization of the Treacher Collins syndrome gene. Genome Res. 1997a;7(3):223-234.
8.
DixonJEllisIBottaniATempleKDixonMJ. Identification of mutations in TCOF1: use of molecular analysis in the pre- and postnatal diagnosis of Treacher Collins syndrome. Am J Med Genet A. 2004;127A(3):244-248.
9.
DixonJHovanesKShiangRDixonMJ. Sequence analysis, identification of evolutionary conserved motifs and expression analysis of murine TCOF1 provide further evidence for a potential function for the gene and its human homologue, TCOF1. Hum Mol Genet. 1997b;6(5):727-737.
10.
DixonJJonesNCSandellLLJayasingheSMCraneJReyJPDixonMJTrainorPA. TCOF1/treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. Proc Natl Acad Sci USA. 2006;103(36):13403-13408.
11.
DixonMJMarresHAEdwardsSJDixonJCremersCW. Treacher Collins syndrome: correlation between clinical and genetic linkage studies. Clin Dysmorphol. 1994;3(2):96-103.
12.
EdwardsSJGladwinAJDixonMJ. The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon. Am J Hum Genet. 1997;60(3):515-524.
13.
FazenLEElmoreJNadlerHL. Mandibulo-facial dysostosis (Treacher-Collins syndrome). Am J Dis Child. 1967;113(4):405-410.
14.
FernandezAORonisML. The Treacher-Collins syndrome. Arch Otolaryngol. 1964;80:505-520.
15.
FranceschettiAKleinD. The mandibulofacial dysostosis; a new hereditary syndrome. Acta Ophthalmol (Copenh). 1949;27(2):143-224.
16.
GrodyWWThompsonBHHudginsL. Whole-exome/genome sequencing and genomics. Pediatrics. 2013;132(Suppl 3):S211-S215.
17.
HayanoTYanagidaMYamauchiYShinkawaTIsobeTTakahashiN. Proteomic analysis of human Nop56p-associated pre-ribosomal ribonucleoprotein complexes. Possible link between Nop56p and the nucleolar protein treacle responsible for Treacher Collins syndrome. J Biol Chem. 2003;278(36):34309-34319.
18.
JiangXIsekiSMaxsonRESucovHMMorriss-KayGM. Tissue origins and interactions in the mammalian skull vault. Dev Biol. 2002;241(1):106-116.
19.
KadakiaSHelmanSNBadheyAKSamanMDucicY. Treacher Collins syndrome: the genetics of a craniofacial disease. Int J Pediatr Otorhinolaryngol. 2014;78(6):893-898.
20.
KatsanisSHJabsEW. Treacher Collins Syndrome. Seattle (WA). Seattle: University of Washington; 1993.
21.
LeeHDeignanJLDorraniNStromSPKantarciSQuintero-RiveraFDasKToyTHarryBYourshawM, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014;312(18):1880-1887.
22.
LevasseurJNysjöJSandyRBrittoJAGarcelonNHaberSPicardACorrePOdriGAKhonsariRH. Orbital volume and shape in Treacher Collins syndrome. J Craniomaxillofac Surg. 2018;46(2):305-311.
23.
LiXSuYHuangSGaoBZhangDWangXGaoQPangHZhaoYYuanY, et al. Genotype-phenotype variability in Chinese cases of Treacher Collins syndrome. Acta Otolaryngol. 2019;139(7):567-575.
24.
MarresHACremersCWDixonMJHuygenPLJoostenFB. The Treacher Collins syndrome. A clinical, radiological, and genetic linkage study on two pedigrees. Arch Otolaryngol Head Neck Surg. 1995;121(5):509-514.
25.
MarszalekBWisniewskiSAWojcickiPKobusKTrzeciakWH. Novel mutation in the 5′ splice site of exon 4 of the TCOF1 gene in the patient with Treacher Collins syndrome. Am J Med Genet A. 2003;123A(2):169-171.
26.
MasottiCArmelin-CorreaLMSplendoreALinCJBarbosaASogayarMCPassos-BuenoMR. A functional SNP in the promoter region of TCOF1 is associated with reduced gene expression and YY1 DNA-protein interaction. Gene. 2005;359(10):44-52.
27.
Morriss-KayGMWilkieAO. Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J Anat. 2005;207(5):637-653.
28.
Noack WattKEAchilleosANebenCLMerrillAETrainorPA. The roles of RNA polymerase I and III subunits Polr1c and Polr1d in craniofacial development and in zebrafish models of Treacher Collins syndrome. PLoS Genet. 2016;12(7):e1006187.
29.
PanZYXuHEChenBTianYAZhangLLZhangSLiuDHLiuHFLiRJHuXX, et al. Treacher Collins syndrome: clinical report and retrospective analysis of Chinese patients. Mol Genet Genomic Med. 2021;9(2):e1573.
30.
PosnickJCal-QattanMMMoffatSMArmstrongD. Cranio-orbito-zygomatic measurements from standard CT scans in unoperated Treacher Collins syndrome patients: comparison with normal controls. Cleft Palate Craniofac J. 1995;32(1):20-24.
31.
RosaFCoutinhoMBFerreiraJPSousaCA. Ear malformations, hearing loss and hearing rehabilitation in children with Treacher Collins syndrome. Acta Otorrinolaringol Esp. 2016;67(3):142-147.
32.
SakaiDDixonJAchilleosADixonMTrainorPA. Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation. Nat Commun. 2016;7(21):10328.
33.
SakaiDTrainorPA. Treacher Collins syndrome: unmasking the role of Tcof1/treacle. Int J Biochem Cell Biol. 2009;41(6):1229-1232.
34.
SakaiDTrainorPA. Face off against ROS: tcof1/treacle safeguards neuroepithelial cells and progenitor neural crest cells from oxidative stress during craniofacial development. Dev Growth Differ. 2016;58(7):577-585.
35.
SanchezELaplace-BuilhéBMau-ThemFTRichardEGoldenbergATolerTLGuignardTGatinoisVVincentMBlanchetC, et al. POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4. Genet Med. 2020;22(3):547-556.
36.
SchaeferEColletCGenevieveDVincentMLohmannDRSanchezEBolenderCEliotMMNürnbergGPassos-BuenoMR, et al. Autosomal recessive POLR1D mutation with decrease of TCOF1 mRNA is responsible for Treacher Collins syndrome. Genet Med. 2014;16(9):720-724.
37.
SchoenwolfGCLarsenWJ. Development of the pharyngeal apparatus and face. Larsen’s Human Embryology. Philadelphia; 2009.
38.
SplendoreAJabsEWFélixTMPassos-BuenoMR. Parental origin of mutations in sporadic cases of Treacher Collins syndrome. Eur J Hum Genet. 2003;11(9):718-722.
39.
SplendoreAJabsEWPassos-BuenoMR. Screening of TCOF1 in patients from different populations: confirmation of mutational hot spots and identification of a novel missense mutation that suggests an important functional domain in the protein treacle. J Med Genet. 2002;39(7):493-495.
40.
SplendoreASilvaEOAlonsoLGRichieri-CostaAAlonsoNRosaACarakushankyGCavalcantiDPBrunoniDPassos-BuenoMR. High mutation detection rate in TCOF1 among Treacher Collins syndrome patients reveals clustering of mutations and 16 novel pathogenic changes. Hum Mutat. 2000;16(4):315-322.
41.
SuPHChenJYChenSJYuJS. Treacher Collins syndrome with a de Novo 5-bp deletion in the TCOF1 gene. J Formos Med Assoc. 2006;105(6):518-521.
42.
TeberOAGillessen-KaesbachGFischerSBöhringerSAlbrechtBAlbertAArslan-KirchnerMHaanEHagedorn-GreiweMHammansC, et al. Genotyping in 46 patients with tentative diagnosis of Treacher Collins syndrome revealed unexpected phenotypic variation. Eur J Hum Genet. 2004;12(11):879-890.
43.
TernerJSTraviesoRChangCBartlettSPSteinbacherDM. An analysis of mandibular volume in Treacher Collins syndrome. Plast Reconstr Surg. 2012;129(4):751e-753e.
TsirkosAIMcMasterMJ. Goldenhar-associated conditions (hemifacial microsomia) and congenital deformities of the spine. Spine (Phila Pa 1976). 2006;31(13):E400-E407.
46.
ValdezBCHenningDSoRBDixonJDixonMJ. The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci USA. 2004;101(29):10709-10714.
47.
VincentMGenevièveDOstertagAMarlinSLacombeDMartin-CoignardDCoubesCDavidALyonnetSVilainC, et al. Treacher Collins syndrome: a clinical and molecular study based on a large series of patients. Genet Med. 2016;18(1):49-56.
48.
WieczorekD. Human facial dysostoses. Clin Genet. 2013;83(6):499-510.
49.
WiseCAChiangLCPaznekasWASharmaMMusyMMAshleyJALovettMJabsEW. TCOF1 Gene encodes a putative nucleolar phosphoprotein that exhibits mutations in Treacher Collins syndrome throughout its coding region. Proc Natl Acad Sci USA. 1997;94(7):3110-3115.
50.
YangMJiangHChenWLiQZhangYLiCPanB. Analysis of rib cartilages anomalies in patients with microtia. J Craniofac Surg. 2016;27(4):862-866.
51.
YelickPCTrainorPA. Ribosomopathies: global process, tissue specific defects. Rare Dis. 2015;3(1):e1025185.
52.
ZhangCAnLXueHHaoSYanYZhangQJinXLiQZhouBFengX, et al. Mutation analysis of TCOF1 gene in Chinese Treacher Collins syndrome patients. J Clin Lab Anal. 2021;35(1):e23567.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
